NCT04938115 2024-06-14
Cell Therapy for CD7 Positive Acute Myeloid Leukemia or Mixed Lineage Leukemia
Hebei Senlang Biotechnology Inc., Ltd.
Phase NA Completed
Hebei Senlang Biotechnology Inc., Ltd.
University of Milano Bicocca
Hebei Senlang Biotechnology Inc., Ltd.